- Home
- MAX vs SIGA Comparison
MAX vs SIGA Comparison
Compare MAX & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- SIGA
- Stock Information
- Founded
- MAX 2014
- SIGA 1995
- Country
- MAX United States
- SIGA United States
- Employees
- MAX N/A
- SIGA N/A
- Industry
- MAX Industrial Machinery/Components
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- MAX Industrials
- SIGA Health Care
- Exchange
- MAX Nasdaq
- SIGA Nasdaq
- Market Cap
- MAX 551.1M
- SIGA 515.1M
- IPO Year
- MAX 2020
- SIGA 1997
- Fundamental
- Price
- MAX $10.36
- SIGA $7.26
- Analyst Decision
- MAX Strong Buy
- SIGA
- Analyst Count
- MAX 6
- SIGA 0
- Target Price
- MAX $17.92
- SIGA N/A
- AVG Volume (30 Days)
- MAX 370.3K
- SIGA 389.2K
- Earning Date
- MAX 08-06-2025
- SIGA 08-05-2025
- Dividend Yield
- MAX N/A
- SIGA 8.25%
- EPS Growth
- MAX N/A
- SIGA N/A
- EPS
- MAX 0.28
- SIGA 1.14
- Revenue
- MAX $1,002,364,000.00
- SIGA $179,639,422.00
- Revenue This Year
- MAX $26.40
- SIGA N/A
- Revenue Next Year
- MAX $10.89
- SIGA $95.31
- P/E Ratio
- MAX $37.35
- SIGA $6.39
- Revenue Growth
- MAX 148.62
- SIGA 3.86
- 52 Week Low
- MAX $7.33
- SIGA $4.95
- 52 Week High
- MAX $20.91
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- MAX 49.78
- SIGA 61.98
- Support Level
- MAX $9.73
- SIGA $6.38
- Resistance Level
- MAX $10.57
- SIGA $7.32
- Average True Range (ATR)
- MAX 0.43
- SIGA 0.27
- MACD
- MAX -0.02
- SIGA -0.02
- Stochastic Oscillator
- MAX 49.03
- SIGA 61.97
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.